ALDX Q1 2018 Earnings — Aldeyra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ALDXAldeyra Therapeutics, Inc.

$290M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+106.9% YoY

Gross Profit

$8M100.0% margin

Operating Income

-$8M-102.3% margin

Net Income

-$8M-101.1% margin

EPS (Diluted)

$-0.43

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$868,415

Balance Sheet

Total Assets

$41M

Total Liabilities

$5M

Stockholders' Equity

$36M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$4M	+106.9%
Gross Profit	$8M	$4M	+106.9%
Operating Income	-$8M	-$5M	-66.6%
Net Income	-$8M	-$5M	-64.9%